Results 281 to 290 of about 1,270,348 (335)
How We Treat Hemolytic Anemia Due to Pyruvate Kinase Deficiency. [PDF]
Tama-Shekan S +3 more
europepmc +1 more source
Targeting pyruvate kinase M2 for the treatment of kidney disease. [PDF]
Chen DQ, Han J, Liu H, Feng K, Li P.
europepmc +1 more source
Pyruvate kinase M2 modulates mitochondrial dynamics and EMT in alveolar epithelial cells during sepsis-associated pulmonary fibrosis. [PDF]
Feng J +10 more
europepmc +1 more source
Increased Plasma Pyruvate Kinase M2 (PK-M2) in Heart Failure: A Novel Biomarker Related to Cardiac Function and its Clinical Implications. [PDF]
Cao L +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
CABI Compendium, 2022
This datasheet on pyruvate kinase deficiency covers Identity, Hosts/Species Affected.
semanticscholar +1 more source
This datasheet on pyruvate kinase deficiency covers Identity, Hosts/Species Affected.
semanticscholar +1 more source
Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
Biochimica et biophysica acta. Reviews on cancer, 2021Pyruvate is irreversibly decarboxylated to acetyl coenzyme A by mitochondrial pyruvate dehydrogenase complex (PDC). Decarboxylation of pyruvate is considered a crucial step in cell metabolism and energetics.
Saleha Anwar +4 more
semanticscholar +1 more source
Clinical Biochemistry, 1990
Pyruvate kinase (PK) deficiency was initially described by Valentine et al. in 1961. Since then, more than 300 cases have been described, including 65 in Japan. PK deficiency is the most common hereditary nonspherocytic hemolytic anemia among several red cell enzyme defects of the Embden-Meyerhof glycolytic pathway.
S, Miwa, H, Fujii
openaire +4 more sources
Pyruvate kinase (PK) deficiency was initially described by Valentine et al. in 1961. Since then, more than 300 cases have been described, including 65 in Japan. PK deficiency is the most common hereditary nonspherocytic hemolytic anemia among several red cell enzyme defects of the Embden-Meyerhof glycolytic pathway.
S, Miwa, H, Fujii
openaire +4 more sources

